Results 211 to 220 of about 74,894 (279)

Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease.

Blood, 2016
M. Telen
semanticscholar   +1 more source

Frequency of Zinc Deficiency Among Thalassemia Major Patients: A Comparative Cross-Sectional Study. [PDF]

Cureus
Hayat U, Zaidi U, Munzir S, Dildar S, Sharif Z, Farzana T, Nizamuddin M, Shamsi T.   +7 more
europepmc   +1 more source

Hydroxyurea effectiveness in children and adolescents with sickle cell anemia: A large retrospective, population‐based cohort

American journal of hematology/oncology, 2017
Maa‐Ohui Quarmyne, W. Dong, R. Theodore, S. Anand, Vaughn Barry, O. Adisa, I. Buchanan, J. Bost, R. Brown, C. Joiner, P. Lane   +10 more
semanticscholar   +1 more source

A mixed-methods evaluation to optimize the existing hospital based sickle cell disease care model from a tribal area of Gujarat, India. [PDF]

J Public Health Res
Dave K, Nirgude A, Desai G, Devare S, Desai S.   +4 more
europepmc   +1 more source

Hyperleukocytosis in a Patient With Chronic Myeloid Leukemia and HIV: A Case Report. [PDF]

Cureus
Chambi-Torres JB, Penate Armesto A, Majekodunmi TO, Angly S, Michel G.   +4 more
europepmc   +1 more source

Encapsulation of hydroxyurea in exosomes derived from adipose mesenchymal stem cells enhances anticancer efficacy in breast cancer. [PDF]

Transl Oncol
Taheri Kangarshahi Z, Ganji SM, Ashrafi F, Abbasi A.   +3 more
europepmc   +1 more source

Genotype Differences and Hydroxyurea Utilization Among Adults With Moderate to Severe Sickle Cell Disease. [PDF]

Pharmacotherapy
Cheng SH, Novelli EM, Kang HA, Newman TV, Suh K.   +4 more
europepmc   +1 more source

Clinical presentation and outcomes of children hospitalized with sickle cell anemia at Gulu regional referral hospital, Uganda: a retrospective cross-sectional study. [PDF]

Sci Rep
Okello K, Okello MO, Chemutai FS, Nakasi E, Ouma RC, Bongomin F, Kayina V.   +6 more
europepmc   +1 more source

Trends in HU utilization and cerebrovascular outcomes before and after publication of the 2014 National Heart, Lung, and Blood Institute sickle cell disease guidelines. [PDF]

Pediatr Hematol Oncol
Dain AS, Li Y, Master S, Bailey CL, Vossough A, Ichord RN, Raffini L, Getz K, Kwiatkowski JL.   +8 more
europepmc   +1 more source